Enhanced recovery in liver transplantation: A value-based approach to complex surgical care

Surgery. 2021 Dec;170(6):1830-1837. doi: 10.1016/j.surg.2021.07.001. Epub 2021 Jul 31.

Abstract

Background: Value-based healthcare focuses on improving outcomes relative to cost. We aimed to study the impact of an enhanced recovery pathway for liver transplant recipients on providing value.

Methods: In total, 379 liver recipients were identified: pre-enhanced recovery pathway (2017, n = 57) and post-enhanced recovery pathway (2018-2020, n = 322). The enhanced recovery pathway bundle was defined through multidisciplinary efforts and included optimal fluid management, end-of-case extubation, multimodal analgesia, and a standardized care pathway. Pre- and post-enhanced recovery pathway patients were compared with regard to extubation rates, lengths of stay, complications, readmissions, survival, and costs.

Results: Pre- and post-enhanced recovery pathway recipient model for end-stage liver disease score and balance of risk scores were similar, although post-enhanced recovery pathway recipients had a higher median donor risk index (1.55 vs 1.39, P = .003). End-of-case extubation rates were 78% post-enhanced recovery pathway (including 91% in 2020) versus 5% pre-enhanced recovery pathway, with post-enhanced recovery pathway patients having decreased median intraoperative transfusion requirements (1,500 vs 3,000 mL, P < .001). Post-enhanced recovery pathway recipients had shorter median intensive care unit (1.6 vs 2.3 days, P = .01) and hospital stays (5.4 vs 8.0 days, P < .001). Incidence of severe (Clavien-Dindo ≥3) complications during the index hospitalization were similar between pre-enhanced recovery pathway versus post-enhanced recovery pathway groups (33% vs 23%, P = .13), as were 30-day readmissions (26% vs 33%, P = .44) and 1-year survival (93.0% vs 94.5%, P = .58). The post-enhanced recovery pathway cohort demonstrated a significant reduction in median direct cost per case ($11,406; P < .001).

Conclusion: Implementation of an enhanced recovery pathway in liver transplantation is feasible, safe, and effective in delivering value, even in the setting of complex surgical care.

MeSH terms

  • Aged
  • End Stage Liver Disease / diagnosis
  • End Stage Liver Disease / economics
  • End Stage Liver Disease / mortality
  • End Stage Liver Disease / surgery*
  • Enhanced Recovery After Surgery*
  • Feasibility Studies
  • Female
  • Health Plan Implementation
  • Hospital Mortality
  • Humans
  • Length of Stay / economics
  • Length of Stay / statistics & numerical data
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / economics
  • Male
  • Middle Aged
  • Patient Readmission / economics
  • Patient Readmission / statistics & numerical data
  • Postoperative Complications / economics
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / prevention & control
  • Retrospective Studies
  • Severity of Illness Index
  • Value-Based Health Insurance*